Glycosaminoglycan and transforming growth factor β1 changes in human plasma and urine during the menstrual cycle, in vitro fertilization treatment, and pregnancy
To access this article, please choose from the options below
P.D.M. has nothing to disclose. G.C. has nothing to disclose. M.F. has nothing to disclose. A.J.L. has nothing to disclose. G.M.C. has nothing to disclose. L.G. has nothing to disclose. S.D. has nothing to disclose.
PII: S0015-0282(08)01182-5
doi:10.1016/j.fertnstert.2008.05.066
© 2009 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights reserved.

